SCHEMBL13603471

SCHEMBL13603471

CNC(=O)c1cc(Oc2ccc(CNC(=O)Nc3cc(C(=O)OC)ccc3NC(C)C)cc2)ccn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDR2 Q16832 2/20 0.51
RAF1 P04049 5/20 0.46
EPHX2 P34913 2/20 0.46
MAPK14 Q16539 3/20 0.46
KDR P35968 7/20 0.45
BRAF P15056 2/20 0.44
MMP13 P45452 1/20 0.43
CSF1R P07333 2/20 0.43
PDGFRA P16234 1/20 0.42
RIPK2 O43353 1/20 0.42
ABL1 P00519 2/20 0.41
PLK4 O00444 1/20 0.41
AURKA O14965 1/20 0.41
MAPK13 O15264 1/20 0.41
JAK2 O60674 1/20 0.41
MAP4K4 O95819 1/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
LYN P07948 1/20 0.41
RET P07949 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL169207 0.87 DDR2 (0.59) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL15574164 0.86 DDR2 (0.53) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL13603473 0.79 DDR2 (0.54) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL13603429 0.79 DDR2 (0.53) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL17000001 0.79 L3MBTL1 (0.61) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL17000002 0.79 DDR2 (0.60) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL15573069 0.78 DDR2 (0.65) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL15574556 0.78 DDR2 (0.70) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL15573077 0.78 DDR2 (0.65) DDR2RAF1EPHX2MAPK14KDR
SCHEMBL15575325 0.78 DDR2 (0.59) DDR2RAF1EPHX2MAPK14KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158076-A1 Methylene Urea Derivatives MERCK PATENT GMBH (DE) 2013-06-20 US disclosed
US-8410143-B2 Methylene urea derivatives MERCK PATENT GMBH (DE) 2013-04-02 US disclosed
US-8410143-B2 Methylene urea derivatives MERCK PATENT GMBH (DE) 2013-04-02 US disclosed
US-20090298885-A1 METHYLENE UREA DERIVATIVES MERCK PATENT GMBH (DE) 2009-12-03 US disclosed
US-20090298885-A1 METHYLENE UREA DERIVATIVES MERCK PATENT GMBH (DE) 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298885-A1 METHYLENE UREA DERIVATIVES BRAF, RAF1, CMPK1 DDR2 4558/4885RAF1 2/4885EPHX2 2163/4885
US-20130158076-A1 Methylene Urea Derivatives BRAF, RAF1, CMPK1 DDR2 4558/4885RAF1 2/4885EPHX2 2163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.